Literature DB >> 9054449

The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components.

U M Wallon1, C M Overall.   

Abstract

The binding properties of the COOH-terminal hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2, 72-kDa gelatinase) were investigated to determine whether the C domain has binding affinity for extracellular matrix and basement membrane components. Recombinant C domain (rC domain) (Gly417-Cys631) was expressed in Escherichia coli, and the purified protein, identified using two antipeptide antibodies, was determined by electrospray mass spectrometry to have a mass of 25,925 Da, within 0.1 Da of that predicted. As assessed by microwell substrate binding assays and by column affinity chromatography, the matrix proteins laminin, denatured type I collagen, elastin, SPARC (secreted protein that is acidic and rich in cysteine), tenascin, and MatrigelTM were not bound by the rC domain. Unlike the hemopexin-like domains of collagenase and stromelysin, the rC domain also did not bind native type I collagen. Nor were native or denatured types II, IV, V, and X collagen, or the NC1 domain of type VII collagen bound. However, binding to heparin and fibronectin (Kd, 1.1 x 10(-6) M) could be disrupted by 0.58-0.76 and 0.3 M NaCl, respectively. Using nonoverlapping chymotrypsin-generated fragments of fibronectin, binding sites for the rC domain were found on both the 40-kDa heparin binding and the 120-kDa cell binding fibronectin domains (Kd values, approximately 4-6 x 10(-7) M). The Ca2+ ion, but not the potential structural Zn2+ ion, were found to be essential for maintaining the binding properties of the protein. The apo-form of the rC domain did not bind heparin, and both ethylenediaminetetraacetic acid and the specific Ca2+ ion chelator 1, 2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid, but not the Zn2+ ion chelator 1,10-phenanthroline, eluted the holo form of the rC domain from both heparin-Sepharose and fibronectin. Inductive coupled plasma mass spectrometry also did not detect a Zn2+ ion in the rC domain. In contrast, reduction with 65 mM dithiothreitol did not interfere with heparin binding, further emphasizing the crucial structural role played by the Ca2+ ion. Together, these data demonstrate for the first time that the hemopexin-like domain of gelatinase A has a binding site for fibronectin and heparin, and that Ca2+ ions are important in maintaining the structure and function of the domain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054449     DOI: 10.1074/jbc.272.11.7473

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Metal ion modulation of cystinyl aminopeptidase.

Authors:  Hilde Laeremans; Heidi Demaegdt; Jean-Paul De Backer; Minh T Le; Veerle Kersemans; Yvette Michotte; Georges Vauquelin; Patrick M L Vanderheyden
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

2.  Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables.

Authors:  J Decock; W Hendrickx; H Wildiers; M R Christiaens; P Neven; M Drijkoningen; R Paridaens
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Interaction of angiogenic microvessels with the extracellular matrix.

Authors:  Laxminarayanan Krishnan; James B Hoying; Hoa Nguyen; Helen Song; Jeffrey A Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-10-12       Impact factor: 4.733

4.  Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.

Authors:  Bon-Hun Koo; Jung Ho Han; Young Il Yeom; Doo-Sik Kim
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 5.  Peripheral membrane associations of matrix metalloproteinases.

Authors:  Steven R Van Doren; Tara C Marcink; Rama K Koppisetti; Alexander Jurkevich; Yan G Fulcher
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-23       Impact factor: 4.739

6.  Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2.

Authors:  Xiaoping Xu; Zhihua Chen; Yao Wang; Yoshishige Yamada; Bjorn Steffensen
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

7.  Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.

Authors:  Ekaterina Morgunova; Ari Tuuttila; Ulrich Bergmann; Karl Tryggvason
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

8.  pH dependence of the enzymatic processing of collagen I by MMP-1 (fibroblast collagenase), MMP-2 (gelatinase A), and MMP-14 ectodomain.

Authors:  Magda Gioia; Giovanni Francesco Fasciglione; Susanna Monaco; Riccardo Iundusi; Diego Sbardella; Stefano Marini; Umberto Tarantino; Massimo Coletta
Journal:  J Biol Inorg Chem       Date:  2010-06-12       Impact factor: 3.358

9.  MMP20 hemopexin domain mutation in amelogenesis imperfecta.

Authors:  S-K Lee; F Seymen; H-Y Kang; K-E Lee; K Gencay; B Tuna; J-W Kim
Journal:  J Dent Res       Date:  2010-01       Impact factor: 6.116

10.  Nuclear magnetic resonance mapping and functional confirmation of the collagen binding sites of matrix metalloproteinase-2.

Authors:  Xiaoping Xu; Margarita Mikhailova; Udayar Ilangovan; Zhihua Chen; Agnes Yu; Sanjay Pal; Andrew P Hinck; Bjorn Steffensen
Journal:  Biochemistry       Date:  2009-06-30       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.